実際の問題を解決するために 設立されました。
EVフィールドには非凡なポテンシャルがあります。不足していたのはインフラです。私たちがそれを構築しています。
私たちが存在する理由
BioThera Solutions was founded to address a critical gap in the extracellular vesicle (EV/exosome) field: the absence of scalable, standardized, and reproducible manufacturing required to bring EV technologies of all kinds into real-world application. We set out to build that infrastructure as a platform, not a single product, and to lay the foundation for every application that comes after the first.
EVが強力な生物学的送達システムであるという成長する科学的証拠にもかかわらず、業界は実験室の結果を商業的に実行可能で一貫して製造された製品に変換することに苦労してきました。問題は生物学ではありません、インフラです。
We are building that infrastructure, and we started where the need was most immediate. Interest in exosome-based skincare has grown quickly, driven by genuine scientific interest and consumer demand, yet the market is crowded with products making bold claims, backed by inadequate characterization, inconsistent particle concentrations, and little regulatory transparency. There is real demand, and a real absence of material that meets rigorous scientific standards.
BioThera was built to close that gap. We bring biomanufacturing expertise to a space that has been underserved by rigorous science: characterization in line with MISEV2023, measured particle concentrations, and documentation for every batch. Our research and development has produced proprietary, patent-pending technology and the capacity to manufacture at scale. For cosmetic applications, we license our technology exclusively to Vesera™, a skincare company, and produce the material it uses.
Cosmetic applications are where the platform first meets the market, and they are only the beginning. The infrastructure we are building, from manufacturing and characterization to the evidence base, is designed to carry across biological sources and applications. Our current platform uses plant-derived vesicles; as we grow, our research extends to animal-derived sources, including human stem cell-derived vesicles, and to therapeutic applications, an important focus for our team.
Build the integrated extracellular vesicle platform the field has been missing: standardized, characterized vesicles, engineered to work across biological sources, for applications that begin with cosmetics and extend well beyond them.
With cosmetic applications as our first commercial use, we are establishing the manufacturing infrastructure, characterization rigour, and evidence base that credible EV applications, including therapeutic ones, require.
To define what credible, science-led EV technology looks like, and to build the biomanufacturing backbone the extracellular vesicle field needs to mature, across every application it reaches.
We are in the early chapters of the EV era. Our ambition is to set the standard for the field by building the manufacturing foundation, characterization rigour, and evidence base that scientists, clinicians, partners, and regulators can trust.
私たちが支持するもの
根本的な科学的透明性
私たちは実証できない主張をしません。すべての製品仕様、特性評価結果、規制状況は正確に伝達されます。曖昧な言葉とマーケティングの誇張には、私たちの運営方法に居場所はありません。
妥協のない卓越性
製造基準、特性評価プロトコル、製剤品質、私たちは開発サイクルのどこにいても、すべての段階で同じ厳格さを適用します。品質は検査されるのではなく、組み込まれています。
イノベーション
EVスペースは初期段階です。EVを臨床的・商業的に実行可能にするために必要な製造インフラはまだ完全には存在しません、私たちが構築しています。これには真の科学的創造性と技術的勇気が必要です。
実行
バイオテクにおいてアイデアは豊富です。厳格で信頼できる実行は稀です。私たちは科学的ポテンシャルと現実世界の展開の間のギャップを埋めます。一貫して、予定通りに、仕様に従って。
Ottawa, Ontario, Canada
BioThera SolutionsはOttawa, Ontarioに本社を置いています。私たちの立地は、規制機関、成長するライフサイエンスエコシステム、私たちの業務の中心となる臨床・研究協力者への近接性を提供します。
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 6N5 Canada
オタワ大学：STEMコンプレックス · Ottawa, Ontario
Company Clarification
BioThera Solutions (Canada) is an independent biotechnology firm specializing in extracellular vesicle (EV) technology. We have no affiliation with Bio-Thera Solutions, Ltd. (China), which focuses on biosimilars and antibody-drug conjugates (ADCs). Our mission is to build the integrated platform that extracellular vesicle technology requires, from research and intellectual property to manufacturing, across the sources and applications of extracellular vesicles.
BioThera Solutionsは選定されたパートナーと独占的に協力します。
科学的・戦略的に強く一致する研究、臨床、産業のパートナーと、厳選して協業しています。
パートナーシップの問い合わせは個別に審査されます。
パートナーシップのお問い合わせESGと責任
BioThera Solutions operates with environmental, social, and governance (ESG) principles built into how we work. Our current vesicles are derived from medicinal plants rather than animal or human tissue, and our biomanufacturing process is designed to be scalable and resource-efficient. We are transparent about our science and communicate clearly with clinical partners, suppliers, and the broader research community. Our governance practices are aligned with Health Canada cosmetic notification requirements, and our scientific reporting follows MISEV (Minimal Information for Studies of Extracellular Vesicles) guidelines. Sustainability and ethical conduct are part of how we build for the long term.